MAPT and Alzheimer disease: In addition to these, neurofilament light protein (NfL) [114], apolipoprotein E (APOE), phosphorylated tau (p-tau), and glial fibrillary acidic protein (GFAP) [115] have also been proposed as plasma biomarkers for AD.